Conquering Hepatitis C And Surviving Treatment

Conquering Hepatitis C and Surviving Treatment This book's whole focus is on killing the virus and making it through the necessary treatment journey. Both authors have followed this path. They reveal the latest in research findings on methods to improve treatment success and how to integrate those crucial results in the HCV treatment process. Nine others share their emotional response to learning of their infection, their decision to begin treatment, experiences while undergoing treatment, and what they are doing now. This book provides the necessary information and tools to follow in their footsteps with confidence. - Gives predictive pre-treatment indicators to success. - Shows steps to take to improve chances of success. - Provides proven methods for side effect management. - Reveals latest research findings with references. "Conquering Hepatitis C and Surviving Treatment should be required reading for people embarking on therapy, as well as for health care providers. It will give patients the tools they need to successfully complete treatment, and the stories from the people who have already gone down that path are motivating." ~Paul Schleinitz, MD, April 20, 2010, Medford, Oregon Companion Web Site: www.hcvshare.org

Hepatitis means an inflammation of the liver, but it also refers to a group of viral infections that affect the liver. There are several types of viral hepatitis, but the most common are A, B, and C. Viral hepatitis is spread through contact with infected blood, bodily fluids, or feces, though it may also result from alcohol and drug use or from other diseases. Acute hepatitis refers to the initial infection and can be mild or severe; chronic hepatitis refers to a serious condition in which the infection lasts six months or longer. Currently, vaccines are available for the prevention of hepatitis A and B viruses. This third edition of Hepatitis delves into the history, causes, and current treatments for this disease, giving valuable and up-to-date information to student researchers. Chapters include: Introduction to Hepatitis The Phases of Hepatitis Looking at the Liver Inflammation and Immune Response Hepatitis A Hepatitis B Hepatitis C.

Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the first of two, examines the feasibility of hepatitis B and C elimination in the United States and identifies critical success factors. The phase two report will outline a strategy for meeting the elimination goals discussed in this report.

Hepatitis C is a serious viral illness that affects the liver. Most often spread by blood-to-blood contact, the majority of people infected with hepatitis C do not know they are infected until liver damage has occurred. Because the hepatitis C virus changes its form frequently, presently there is no vaccine for HCV; but once diagnosed, effective treatment is available for many. Written for people diagnosed with hepatitis C and under the care of a physician, this informative book is designed to answer questions about the condition and allow the reader to play an active role in its treatment.

The field of HCV has changed perhaps faster than any other field in medicine. The Guest Editors have strived to create an issue that is a state-of-the-art analysis of solutions to specific challenges faced in the United States and globally in implementing HCV elimination strategies. They believe that clinicians now have the tools and road maps needed to accomplish this goal. The clinical review articles in this issue accomplish that: Using Existing Health Care Infrastructure To Expand HCV Care; Creating A Reproducible Health Economic Model To Describe The Burden Of HCV And Cost Of Treatment In Any Country; The Best Uses Of Cost-Effectiveness Models In HCV; Increasing Access To HCV Care In Corrections; Cure As Prevention Strategies For HCV In People Who Inject Drugs; Australia Will Eliminate HCV – How It Works; New York Is The First State In The US To Develop An HCV Elimination Strategy; When HCV Diagnostics Are The Barrier To Care; Key Findings From The Checs HCV Cohort Study; Strategies To Reduce HCV Reinfection Rates In People Who Inject Drugs; Strategies To Reduce HCV Reinfection Rates In Men Who Have Sex With Other Men; The Value Of Curing HCV From A Payer’s Perspective; How To Expand Care Capacity In HCV; Strategies To Eliminate HCV In The HIV Coinfected Population; and The US Veteran’s Administration: Lessons Learned And Best Practices For HCV Elimination.

Viral Proteases and Their Inhibitors provides a thorough examination of viral proteases from their molecular components, to therapeutic applications. As information on three dimensional structures and biological functions of these viral proteases become known, unexpected protein folds and unique mechanisms of proteolysis are realized. This book investigates how this facilitates the design and development of potent antiviral agents used against life-threatening viruses. Users will find descriptions of each virus that detail the structure and function of viral proteases, discuss the design and development of inhibitors, and analyze the structure-activity relationships of inhibitors. This book is ideal biochemists, virologists and those working on antiviral agents. Provides comprehensive, state-of-the-art coverage of virus infections, the virus lifecycle, and mechanisms of protease inhibition Analyzes structure-activity relationships of inhibitors of each viral protease Presents an in-depth view of the structure and function of viral proteases

Hepatitis C Treatment One Step at a Time provides the practical advice and daily inspiration you need to help you successfully complete hepatitis C (HCV) treatment. Deciding to undergo HCV antiviral therapy is one of the bravest and most important steps toward health you'll ever make. As a nurse in the HCV field and a patient who underwent three courses of HCV therapy, Lucinda K. Porter understands how physically and emotionally challenging this experience can be. In Hepatitis C Treatment One Step at a Time, she provides entries for each day of treatment, offering you a daily dose of relief, encouragement, and tips to help you stay on track. From dealing with fatigue and nausea to nosy co-workers and lab results, Porter shows you how to: Prepare mentally, physically, and financially Manage side effects Set up a support system Keep your spirits up Celebrate your strength and acknowledge your milestones Find additional help and up-to-date information with an extensive resources section